Auwaerter on Infectious Diseases

Paul G. Auwaerter, MD, MBA, has disclosed no relevant financial relationships. Dr. Auwaerter is a paid consultant to Medscape, and his participation and contributions do not constitute endorsement by The Johns Hopkins University, Hospital, or Health System.
- Monoclonals for COVID-19 a 'Minor Contribution'
- SARS-CoV-2 Diagnostics, From Serology to Spit
- 'Warning Lights' Ahead: Insights From COVID Epidemiology
- Highlights From IDWeek 2020: Fauci on COVID-19
- 'No One Is Protected' From COVID-19, Not Even the President
- This 'Slowly Evolving Crisis' Needs Attention
- Cases Are Up, Mask Use Is Down -- Let's Reverse That
- 'Thinnest Threads of Evidence' for COVID-19 Treatments
- Coronaviruses: What We Know Now
- Infectious Diseases in 2020: 5 Areas of Concern
- Auwaerter's Highlights From IDWeek 2019
- Lyme Testing Gets Fast and Easy
- Will This Be the Holy Grail for Sepsis?
- Severe Malaria: Only One Drug Option Remains
- 'Zombie Deer Disease' Spreading; Watch What You Eat
- Baloxavir's Place in the Treatment of Flu
- Are Showerheads Causing Chronic Lung Infections?
- Oral Antibiotics for Infective Endocarditis: Time to Switch?
- Fever of Unknown Origin in an Adult-- Periodic Fever Syndromes?
- A Call for a Lyme Disease Vaccine